In the BioHarmony Drug Report Database

"Preview" Icon

Edoxaban

Savaysa, Lixiana, Roteas (edoxaban) is a small molecule pharmaceutical. Edoxaban was first approved as Savaysa on 2015-01-08. It is used to treat pulmonary embolism and venous thrombosis in the USA. It has been approved in Europe to treat stroke and venous thromboembolism. The pharmaceutical is active against coagulation factor X. Savaysa’s patent is valid until 2028-03-28 (FDA).

 

Trade Name

 

Lixiana, Roteas
 

Common Name

 

edoxaban
 

ChEMBL ID

 

CHEMBL1269025
 

Indication

 

pulmonary embolism, stroke, venous thromboembolism, venous thrombosis
 

Drug Class

 

Antithrombotic: blood coagulation factor XA inhibitors

Image (chem structure or protein)

Edoxaban structure rendering